News
2021-06-10 10:45
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management announces that it is launching a pilot project with twenty selected people from a group of several...
2021-06-09 14:50
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management decided in November 2018 on a warrant program, TO 6 B. The exercise period for the warrants of...
2021-06-08 09:45
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management announces today that the company's pharmaceutical robot Dosell has been registered in the...
2021-05-03 12:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management updates the market on the latest developments of the next generation of Dosell - Dosell 2.0 which...
2021-04-29 08:30
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - today April 29, releases its Q1 Interim Report 2021. Read the full report here. Summary of financial performance Important events in the quarter Important events since the...
2021-04-26 10:00
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related...
2021-04-21 10:50
iZafe Group AB (publ) (“iZafe Group” or “the Company”) issued 1,000,000 warrants (TO9) in connection with the procurement of a credit facility during April 2020. The exercise period for the TO 9 series warrants began on 12 April...
2021-03-04 11:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management – announces that it has completed a pilot project with the healthcare company TioHundra...
2021-02-25 11:00
Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - a leading Life-Science company in healthcare digitalization announces that the company's major shareholders have appointed a nomination committee. iZafe Group AB's major...
2021-02-24 16:45
Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - a leading Life-Science company in healthcare digitalization announces an expansion of its information provided to shareholders and other stakeholders. As a complement to the communication...
2021-02-19 08:30
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - today February 19, releases its year-end report of the forth quarter 2020. Read the full report here. Condensed statement of financial performance Significant events during...
2021-02-18 15:30
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B), a leading Life Science company focused on the digitalisation of healthcare, is announcing that the board of directors of iZafe Group AB (“iZafe” or “the company”)...
2021-02-17 09:00
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related...
2021-02-01 13:02
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B), a leading Life Science company focused on the digitalisation of medication handling, is announcing the completion of a pilot project with private care provider Attendo. The...
2020-12-22 09:00
In November 2019, iZafe Group AB (publ) (“iZafe” or “the Company”), a leading Life Science company forcused on the digitalisation of medication handling, completed a rights issue in the form of shares and free warrants. The exercise...
2020-12-16 10:45
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading life science company focused on the digitalization of medication management, is announcing that it already at an early stage has received in total 450 pre-orders...
2020-12-16 09:00
Stockholm, Sweden and Espoo, Finland – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading life science company focused on the digitalization of medication management, is announcing the launch of two pilot projects in two Finnish...
2020-12-16 08:30
The exercise period for series TO 8 B warrants issued in connection with the rights issue of units by iZafe Group AB (publ) in November 2019 continues up to and including December 18, 2020. The last day of trading in series TO 8 B warrants on First North...
2020-12-15 11:15
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B), a leading company focused on the digitalisation of medication handling, is announcing that it is entering into a collaborative partnership with Doro in Sweden as a direct result...
2020-12-14 17:00
Stockholm, Sweden and Seattle, USA – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading Life Science company focused on the digitalization of medication management announced it has signed a partnership agreement with Hippo Technologies...
2020-12-10 10:00
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B), a leading Life Science company focused on the digitalisation of medication handling, is announcing that it will begin delivering a consumer version of Dosell in spring 2021...